| 000 | 01592 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517031634.0 | ||
| 264 | 0 | _c20160321 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1095-8274 | ||
| 024 | 7 |
_a10.1016/j.anaerobe.2015.05.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMackin, Kate E | |
| 245 | 0 | 0 |
_aMolecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia. _h[electronic resource] |
| 260 |
_bAnaerobe _cAug 2015 |
||
| 300 |
_a80-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Toxins _xgenetics |
| 650 | 0 | 4 |
_aClostridioides difficile _xclassification |
| 650 | 0 | 4 |
_aClostridium Infections _xmicrobiology |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aFluoroquinolones _xpharmacology |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetronidazole _xpharmacology |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMoxifloxacin |
| 650 | 0 | 4 |
_aVancomycin _xpharmacology |
| 650 | 0 | 4 | _aVictoria |
| 700 | 1 | _aElliott, Briony | |
| 700 | 1 | _aKotsanas, Despina | |
| 700 | 1 | _aHowden, Benjamin P | |
| 700 | 1 | _aCarter, Glen P | |
| 700 | 1 | _aKorman, Tony M | |
| 700 | 1 | _aRiley, Thomas V | |
| 700 | 1 | _aRood, Julian I | |
| 700 | 1 | _aJenkin, Grant A | |
| 700 | 1 | _aLyras, Dena | |
| 773 | 0 |
_tAnaerobe _gvol. 34 _gp. 80-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.anaerobe.2015.05.001 _zAvailable from publisher's website |
| 999 |
_c24872003 _d24872003 |
||